Viewing nowCombinationCordiovan Tablets 160/12.5 mg (Valsartan, Hydrochlorothiazide)
Valsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.

MFDS item code 200209695 · Notified 2002.03.28 · Insurance code 653601050
Treatment of essential hypertension not controlled with monotherapy
This medication helps effectively manage blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy. It stabilizes blood pressure and reduces cardiovascular risks for patients requiring combination therapy. This ultimately lowers the risk of complications from hypertension and improves overall health.
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when valsartan 160 mg/hydrochlorothiazide 12.5 mg has been prescribed to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not exceed 80 mg of valsartan per day.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so use should be discontinued immediately upon confirmation of pregnancy. Individuals with allergies to this medication or sulfonamide drugs, or with severe liver or kidney disease, should not use it. Patients with electrolyte imbalance, volume depletion, kidney and liver dysfunction, elderly patients, and those with diabetes should take this medication with caution and require regular monitoring. This medication can cause symptoms such as dizziness or drowsiness; therefore, caution should be exercised when driving or operating machinery. If taken with potassium supplements or potassium-containing medications, serum potassium levels may become dangerously high, so consultation with a doctor is advised. This medication can interact with other antihypertensive drugs, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), so it is essential to inform your physician of any medications being taken. There may be an increased risk of skin cancer, so avoid exposure to sunlight and report any skin abnormalities to a doctor immediately. In case of overdose, symptoms such as hypotension, arrhythmia, electrolyte abnormalities may occur, so dosages must be strictly followed, and if any unusual symptoms occur, immediate consultation with healthcare professionals is necessary. Safety in children has not been established, and nursing women are advised to avoid taking this medication.
headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, arthralgia, abdominal pain, upper abdominal pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, dyspnea, erectile dysfunction, colitis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramp, myofascial pain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, dysesthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, pruritus, serum sickness, vasculitis, hair loss, kidney damage, myalgia, anaphylaxis-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, angioedema, rash, vesicular dermatitis, renal failure, arthralgia, weakness, low back pain, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, hypokalemia, elevated blood lipids, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, hyperglycemia, diabetes, worsening of diabetic metabolism, urticaria, skin rash, photosensitivity reaction, necrotizing vasculitis, lupus erythematosus with skin lesions, anorexia, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disorder, depression, dysesthesia, visual impairment, leukopenia, acute respiratory distress syndrome, pneumonia, pulmonary edema, acute renal failure, renal impairment, erythema multiforme, fever, muscle cramp, acute angle-closure glaucoma, choroidal effusion, nausea, drowsiness, hypovolemia, arrhythmia, muscle stiffness
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container in a cool place below 30 degrees Celsius. Storing it this way helps maintain the medication’s effectiveness for a longer period.
Dark red oval film-coated tablet
98 tablets (14 tablets/PTP packaging x 7)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Hydrochlorothiazide
Prescription medication · Combination
Sandoz Korea Co., Ltd.
Valsartan · Hydrochlorothiazide
Prescription medication · Combination
Sandoz Korea Co., Ltd.
CombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.